Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Varian Medical Systems Inc (NYSE:VAR)

106.69
Delayed Data
As of Oct 20
 +1.09 / +1.03%
Today’s Change
75.94
Today|||52-Week Range
107.87
+34.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$9.7B

Company Description

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical condition. It operates through the following segments. Oncology Systems, Imaging Components, and Other. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiotherapy, and advance treatments such as fixed field intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. The Imaging Components segment comprises of radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer-aided diagnostics, and industrial applications. The Other segment includes Varian Particle Therapy, and Ginzton Technology Center. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

Contact Information

Varian Medical Systems, Inc.
3100 Hansen Way
Palo Alto California 94304-1038
P:(650) 493-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders56.08%
Other institutional47.33%
Individual stakeholders0.61%

Top Executives

Dow R. WilsonPresident, Chief Executive Officer & Director
Gary E. BischopingChief Financial Officer
Corey ZankowskiChief Technology Innovation Officer & Senior VP
Jessica L. DenecourChief Information Officer & Senior Vice President
Deepak KhuntiaChief Medical Officer & Senior Vice President